Merck Settles Over 200 Gardasil HPV Vaccine Lawsuits for More Than $50 Million
Pharmaceutical giant Merck & Co. announced on June 4, 2026, that it will pay over $50 million to settle more than 200 lawsuits alleging that its Gardasil HPV vaccine caused autoimmune ailments — including postural orthostatic tachycardia syndrome (POTS) and premature ovarian insufficiency — in young women. Merck is not admitting liability and describes the settlement amount as 'not material' to the firm, while reaffirming the vaccine's safety and efficacy. One case, involving plaintiff Jennifer Robi in California, remains outstanding.